Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | -.--% | +526.50% |
May. 24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
May. 23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 71.68M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.76
x | P/E ratio 2025 * |
-11.1
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.54% |
1 day | +0.58% | ||
1 month | +2.86% | ||
3 months | +261.10% | ||
6 months | +449.88% | ||
Current year | +526.50% |
1st Jan change | Capi. | |
---|---|---|
+526.50% | 71.68M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- LABP Stock